Square Pharmaceuticals

Square Pharmaceuticals Ltd. (Gazipur)

Square Pharmaceuticals Ltd. is the largest pharmaceutical company in Bangladesh and has been a leader in the country's pharmaceutical sector for several decades. Founded in 1958 by Samson H. Chowdhury along with three of his friends, Square Pharmaceuticals began as a small trading company before evolving into a manufacturer of pharmaceutical products in 1964. The company's headquarters are located in Dhaka, Bangladesh, with its manufacturing plants situated in the Pabna and Gazipur districts. Square Pharmaceuticals is a flagship company of Square Group, which has diversified interests in various sectors including textiles, consumer goods, and information technology.

History

Square Pharmaceuticals Ltd. was established with a vision to provide quality medicines to the people of Bangladesh at an affordable price. Over the years, the company has significantly expanded its operations and product range. In the 1980s, it became the first company in Bangladesh to meet the Good Manufacturing Practices (GMP) as per the guidelines of the World Health Organization (WHO). This milestone was pivotal in establishing Square Pharmaceuticals as a trusted name in the pharmaceutical industry, both domestically and internationally.

Operations

The company's operations encompass the entire spectrum of pharmaceutical manufacturing, including the production of generic drugs, over-the-counter (OTC) medicines, and active pharmaceutical ingredients (APIs). Square Pharmaceuticals operates under international standards, ensuring high-quality products are delivered to the market. It has also ventured into biotechnology, aiming to produce biosimilar drugs that can provide more affordable options for critical care.

International Presence

Square Pharmaceuticals has extended its reach beyond Bangladesh, exporting its products to more than 50 countries around the world. The company has established a strong presence in Southeast Asia, Africa, and the Gulf region, adhering to international regulatory standards. This global expansion has not only contributed to the company's growth but also positioned Bangladesh as a significant player in the global pharmaceutical industry.

Research and Development

Innovation is at the core of Square Pharmaceuticals' operations. The company invests heavily in its research and development (R&D) facilities to develop new formulations and ensure the highest quality of its products. Its R&D efforts are focused on meeting both local and international health care needs, with a commitment to affordability and accessibility.

Corporate Social Responsibility

Square Pharmaceuticals is deeply committed to corporate social responsibility (CSR). The company undertakes various initiatives aimed at improving health care, education, and social welfare in Bangladesh. Through its CSR programs, Square Pharmaceuticals strives to make a positive impact on the community and the environment.

Future Outlook

As Square Pharmaceuticals continues to grow, it remains focused on innovation, quality, and expanding its international footprint. The company is exploring new markets and investing in advanced technologies to meet the evolving needs of the healthcare industry. With a strong foundation and a clear vision, Square Pharmaceuticals is poised for further success in the years to come.

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia